fda tirzepatide ban US proposes curbs on mass compounding of Novo, Lilly's weight-loss drugs An FDA Reversal on Peptides

It is the targeted modulation of the biological systems that drive metabolic decline, body composition changes, and long-term healthspan during and after the menopausal transition

Both routes are effective, but Maximus typically recommends subcutaneous injections

Originally developed for diabetes and weight loss, these medications are now being recognized for their profound benefits in treating core drivers of PCOS , including insulin resistance , excess androgens , and chronic inflammation

Healthcare providers may maintain patients at lower doses if therapeutic goals are achieved or if higher doses are not well tolerated